These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. RS4651 suppresses lung fibroblast activation via the TGF-β1/SMAD signalling pathway. Li S; Xu A; Li Y; Tan C; La Regina G; Silvestri R; Wang H; Qi W Eur J Pharmacol; 2021 Jul; 903():174135. PubMed ID: 33940030 [TBL] [Abstract][Full Text] [Related]
3. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway. Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376 [TBL] [Abstract][Full Text] [Related]
4. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis. Zhang L; Li Y; Liang C; Yang W Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150 [TBL] [Abstract][Full Text] [Related]
5. Silencing lncRNA Snhg6 mitigates bleomycin-induced pulmonary fibrosis in mice via miR-26a-5p/TGF-β1-smads axis. Deng W; Zhang Y; Fang P; Shi H; Yang S Environ Toxicol; 2022 Oct; 37(10):2375-2387. PubMed ID: 35785413 [TBL] [Abstract][Full Text] [Related]
6. GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGFβ1/Smad-Mediated Epithelial-to-Mesenchymal Transition. Zhou XM; Wang GL; Wang XB; Liu L; Zhang Q; Yin Y; Wang QY; Kang J; Hou G Front Pharmacol; 2017; 8():904. PubMed ID: 29311918 [No Abstract] [Full Text] [Related]
7. Fucoxanthin inhibits profibrotic protein expression in vitro and attenuates bleomycin-induced lung fibrosis in vivo. Ma SY; Park WS; Lee DS; Choi G; Yim MJ; Lee JM; Jung WK; Park SG; Seo SK; Park SJ; Han IY; Choi YH; Choi IW Eur J Pharmacol; 2017 Sep; 811():199-207. PubMed ID: 28642129 [TBL] [Abstract][Full Text] [Related]
9. Stevioside attenuates bleomycin-induced pulmonary fibrosis by activating the Nrf2 pathway and inhibiting the NF-κB and TGF-β1/Smad2/3 pathways. Hao W; Yu TT; Zuo DZ; Hu HZ; Zhou PP Exp Lung Res; 2023 Nov; 49(1):205-219. PubMed ID: 38044666 [No Abstract] [Full Text] [Related]
10. Induced Pluripotent Stem Cells Inhibit Bleomycin-Induced Pulmonary Fibrosis in Mice through Suppressing TGF-β1/Smad-Mediated Epithelial to Mesenchymal Transition. Zhou Y; He Z; Gao Y; Zheng R; Zhang X; Zhao L; Tan M Front Pharmacol; 2016; 7():430. PubMed ID: 27895584 [TBL] [Abstract][Full Text] [Related]
11. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis]. Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520 [TBL] [Abstract][Full Text] [Related]
12. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis. Mou F; Mou C Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905 [TBL] [Abstract][Full Text] [Related]
13. Capsaicin ameliorate pulmonary fibrosis via antioxidant Nrf-2/ PPAR- γ pathway activation and inflammatory TGF-β1/ NF-κB/COX II pathway inhibition. Abdulaal WH; Asfour HZ; Helmi N; Al Sadoun H; Eldakhakhny B; Alhakamy NA; Alqarni HM; Alzahrani SAM; El-Moselhy MA; Sharkawi SS; Aboubakr EM Front Pharmacol; 2024; 15():1333715. PubMed ID: 38449809 [TBL] [Abstract][Full Text] [Related]
14. Paeoniflorin, the main active constituent of Paeonia lactiflora roots, attenuates bleomycin-induced pulmonary fibrosis in mice by suppressing the synthesis of type I collagen. Ji Y; Wang T; Wei ZF; Lu GX; Jiang SD; Xia YF; Dai Y J Ethnopharmacol; 2013 Oct; 149(3):825-32. PubMed ID: 23973787 [TBL] [Abstract][Full Text] [Related]
15. Costunolide inhibits pulmonary fibrosis via regulating NF-kB and TGF-β Liu B; Rong Y; Sun D; Li W; Chen H; Cao B; Wang T Biochem Biophys Res Commun; 2019 Mar; 510(2):329-333. PubMed ID: 30709583 [TBL] [Abstract][Full Text] [Related]
16. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition. Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658 [TBL] [Abstract][Full Text] [Related]
17. LOXL2, a copper-dependent monoamine oxidase, activates lung fibroblasts through the TGF-β/Smad pathway. Wen X; Liu Y; Bai Y; Li M; Fu Q; Zheng Y Int J Mol Med; 2018 Dec; 42(6):3530-3541. PubMed ID: 30320382 [TBL] [Abstract][Full Text] [Related]
18. Sphingosine Kinase 1/S1P Signaling Contributes to Pulmonary Fibrosis by Activating Hippo/YAP Pathway and Mitochondrial Reactive Oxygen Species in Lung Fibroblasts. Huang LS; Sudhadevi T; Fu P; Punathil-Kannan PK; Ebenezer DL; Ramchandran R; Putherickal V; Cheresh P; Zhou G; Ha AW; Harijith A; Kamp DW; Natarajan V Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192225 [TBL] [Abstract][Full Text] [Related]
19. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition. Gao L; Jiang D; Geng J; Dong R; Dai H Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412 [TBL] [Abstract][Full Text] [Related]
20. Juglanin alleviates bleomycin-induced lung injury by suppressing inflammation and fibrosis via targeting sting signaling. Sun SC; Han R; Hou SS; Yi HQ; Chi SJ; Zhang AH Biomed Pharmacother; 2020 Jul; 127():110119. PubMed ID: 32276127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]